Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Phase 2b Ifenprodi study to begin in Q3

View:

Post by StockHawk1 on Jan 13, 2023 5:55pm

Phase 2b Ifenprodi study to begin in Q3

Algernon Pharmaceuticals (AGN.c AGNPF) to start its Phase 2b clinical study of Ifenprodi for the treatment of chronic cough in Q3 of 2023.

This study comes after the Phase 2a study which showed that Ifenprodil reduced patient cough counts.

AGN to also file an investigational new drug application for Ifenprodi with the FDA.